For: | Cao Y, Shu XB, Yao Z, Ji G, Zhang L. Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis? World J Gastroenterol 2020; 26(38): 5812-5821 [PMID: 33132636 DOI: 10.3748/wjg.v26.i38.5812] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i38/5812.htm |
Number | Citing Articles |
1 |
Rose Anne M Abe, Anum Masroor, Arseni Khorochkov, Jose Prieto, Karan B Singh, Maduka C Nnadozie, Muhammad Abdal, Niki Shrestha, Lubna Mohammed. The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review. Cureus 2021; doi: 10.7759/cureus.16855
|
2 |
Ting Hong, Yiyan Chen, Xiaoying Li, Yan Lu, Jun Pu. The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/6889533
|
3 |
Navya Malladi, Devidas Lahamge, Balaji Sanjay Somwanshi, Vikas Tiwari, Kajal Deshmukh, Jagdish Kumar Balani, Samhita Chakraborty, Md Jahangir Alam, Sanjay K. Banerjee. Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation. Cellular Signalling 2024; 121: 111299 doi: 10.1016/j.cellsig.2024.111299
|
4 |
Ioanna Aggeletopoulou, Efthymios P. Tsounis, Christos Triantos. Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights. International Journal of Molecular Sciences 2024; 25(9): 4901 doi: 10.3390/ijms25094901
|
5 |
Kota Kurosaki, Yoshihiro Uesawa. Molecular Initiating Events Associated with Drug-Induced Liver Malignant Tumors: An Integrated Study of the FDA Adverse Event Reporting System and Toxicity Predictions. Biomolecules 2021; 11(7): 944 doi: 10.3390/biom11070944
|
6 |
Mauro Giuffrè, Nicola Merli, Maura Pugliatti, Rita Moretti. The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review. International Journal of Molecular Sciences 2024; 25(6): 3337 doi: 10.3390/ijms25063337
|
7 |
Basma A. Abdelrahman, Olfat A. Hammam, Aiman S. El-Khatib, Yasmeen M. Attia. The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH. Biochemical and Biophysical Research Communications 2023; 688: 149122 doi: 10.1016/j.bbrc.2023.149122
|
8 |
Jingqi Liu, Yang Song, Ye Wang, Huashan Hong. Vitamin D/vitamin D receptor pathway in non-alcoholic fatty liver disease. Expert Opinion on Therapeutic Targets 2023; 27(11): 1145 doi: 10.1080/14728222.2023.2274099
|
9 |
Ling Wang, Hongzhao Lu, Shanshan Wang, Huan Liu, Miaomiao Guo, Hao Bai, Wenxian Zeng, Tao Zhang. Vitamin D Receptor affects male mouse fertility via regulation of lipid metabolism and testosterone biosynthesis in testis. Gene 2022; 834: 146589 doi: 10.1016/j.gene.2022.146589
|
10 |
Paloma Sangro, Manuel de la Torre Aláez, Bruno Sangro, Delia D’Avola. Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment. Journal of Physiology and Biochemistry 2023; 79(4): 869 doi: 10.1007/s13105-023-00954-4
|
11 |
Basma A. Abdelrahman, Aiman S. El-Khatib, Yasmeen M. Attia. Insights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease. Life Sciences 2023; 332: 122124 doi: 10.1016/j.lfs.2023.122124
|
12 |
Piero Portincasa, Mohamad Khalil, Laura Mahdi, Valeria Perniola, Valeria Idone, Annarita Graziani, Gyorgy Baffy, Agostino Di Ciaula. Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options. International Journal of Molecular Sciences 2024; 25(11): 5640 doi: 10.3390/ijms25115640
|
13 |
Ricardo Amorim, Pedro Soares, Daniel Chavarria, Sofia Benfeito, Fernando Cagide, José Teixeira, Paulo J. Oliveira, Fernanda Borges. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities. European Journal of Medicinal Chemistry 2024; 277: 116723 doi: 10.1016/j.ejmech.2024.116723
|